The pathway of normal B cell activation is a network of complex regulatory events (1-3). Although the goal of a directed immune response is to generate antigen-specific antibodies, a large component of this response is actually polyclonal and nonspecific. Examples of this phenomenon are seen regularly with antigen-specific immunization, as there is a concomitant rise in antibody titers directed against noncrossreacting antigens (4). This nonspecificity appears to be mediated, in large part, by soluble factors that stimulate either growth or differentiation of local B cell clones (1-3, 5, 6) . Current models of lymphokine regulation of B cell maturation suggest that resting, Go B cells are preactivated by antigen in vivo, or anti-IgM antibodies in vitro, to become responsive to B cell-stimulatory factor (BSF-1, reference 1).' After exposure to growth factors, B cells proliferate and generate receptors for factors regulating terminal maturation, antibody production, and secretion (B cell differentiation factors [BCDF], 1-3). Recently, it has become evident that such a model is not sufficient to explain the heterogeneity of B cell growth (7) and differentiation (8) factors. Furthermore, we and others (8-10) have now described nonspecific proliferationinducing factors (B cell proliferation factor [BCPF] and BSF-1) that act on resting, Go B cells without preactivation, a finding that suggests that, even at this early stage, B cells have receptors for growth factors .
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B cells undergoing active proliferation do not result in terminal maturation to Ig-secreting cells. To address this observation more directly, we sought to determine the effects of factors inducing proliferation on the B cell response to BCDF(s). Either high-dose SAC (0 .1-0 .01% vol/vol) or BCPF (10-1%) were added on day 0 to cultures of isolated B cells with one of four different BCDF preparations . As can be seen in Table I , in each case where active proliferation is noted, the response to BCDF(s) was blunted or absent, compared with cultures without any proliferation signal . This inhibition was reversed as the degree of proliferation decreased, with lower concentrations of SAC or BCPF . This inhibition of maturation was not due to a change in the kinetics of the BCDF response ( Fig. 1) , as no PFC response was demonstrable up to day 12 when BCPF was added on day 0 . Furthermore, even when BCDF was added from 24-96 h after SAC or BCPF, no terminal differentiation was noted, suggesting that these proliferative signals were not delaying expression of receptors for BCDF . Supernatants of proliferating B cells (induced by SAC) did not, in themselves, induce inhibition of BCDF response, showing that proliferating B cells were not secreting any inhibitory factors (data not shown) . In addition, the inhibition could not be reversed by replacing cultures with fresh medium nor by changes in cell concentrations, suggesting that nutrient depletion and crowding did not appear to play a role (data not shown) . Differentiation Occurs in the Absence of Proliferation. To further characterize the role, if any, of proliferation in normal B cell maturation, we added varying concentrations of HU (10-3 -10-7 M) to cultures of B cells and any one of four different BCDF preparations . These concentrations of HU were shown, in separate experiments, to block both T and B cell responses to mitogens and antigens (Table II and data not shown) . As noted in Table II Proliferation-dependent and -independent BCDFs *Varying concentrations of HU (10-s -10-7 M) are added to cultured B cells ± BCDF on day 0. Dose range was chosen for ability to inhibit both T (PHA) and B (SAC) cell mitogen responses; at 10-s M, 100% inhibition for T and B; 10 -4 , 90% T/93% B; 10 -5 , 91% T/95% B; 10-6 , 82% T/91% B; 10-', 61% T/53% B. *As per Table I . ¢Viability and recovery of 10 6 B cells in culture on day 6 t HU as follows: no HU, 71% ; 10 -s M, 23%; 10-4 M,48%;10-' M,76%; 10-6 M, 73%; 10 -7 M, 70%. and viability. In contrast, both MOPIL and MOW 10 induce PFC responses comparable to control cultures in the presence of 10 -5 and 10 -6 M HU . At higher concentrations (10-s and 10-4 M) both cell recovery and viability were reduced, accounting for the marked inhibition of all responses (Table 11) ; however, at lower concentrations (10-5 -10-7 M) cell recovery and viability were unaffected . Similar data were obtained using thymidine blockade (data not shown) . These findings suggest that there may be two types of BCDF(s): A proliferation-dependent variety, analogous to the conventional T cell and PWM signal ; and a proliferation-independent type that can induce terminal maturation without expansion of the B cell clone. Furthermore, this provides additional evidence for the heterogeneity of B cell differentiation factors, as previously proposed (8, 9) .
Proliferation-independent BCDFs Induce Terminal Maturation ofDense Resting B
Cells. An alternative explanation for the findings noted above is that both MOP IL and MOW 10 are acting on B cells that have either already undergone proliferation or have been activated in vivo . To isolate purer populations of resting and activated cells, B cells were separated by counterflow elutriation. In Fig. 2 profiles of unseparated non-T cells, as well as eight isolated fractions, are depicted by size and cell volume (range, 140-215 um). The staining characteristics of each fraction are noted in Table III . The early fractions (1-3) are remarkable for the absence of any activation marker (4F2, Tac) . The 4F2+ cells increase thereafter to a maximum in fraction 8 (macrophages). Tac was present in fractions 5-7, with peak staining in fraction 6.
Each fraction was analyzed for response to three different B cell maturation signals, MOW 10 (our proliferation-independent BCDF), SAC and IL-2, a more conventional pure B cell signal (19) and IL-2, recently shown to induce differentiation of Tac+ B cells (20) (21) (22) (23) . Fig. 3 depicts a representative experiment . The response to MOW 10 appears to reside in the early B cell fractions, corresponding with the dense resting B cell . In contrast, IL-2 only affects terminal maturation of Tac+-activated B cells, confirming data reported by others (24) . The combined signal of SAC and IL-2 is effective in virtually all fractions and is probably related to the ability of SAC to induce Tac positivity on B cells (25) . Thus it appears that MOW 10 is acting on dense resting 4F2-B cells, not in vivo-activated cells, and suggests that even resting B cells have a full complement of receptors for both growth and differentiation factors . Discussion Some previous models of B cell maturation have suggested that B cell proliferation is an integral and necessary prerequisite for terminal maturation and antibody secretion. The data presented in this study directly conflict with such a schema, and extend previous observations of malignant B cell clones (11) and of the murine system (13) (14) . Using response to T cell hybridoma-derived BCDFs as an assay for terminal maturation, we have shown that active proliferation of B cells actually inhibits B cell differentiation, as measured by antibody secretion. These data were reproducible using two different B cell proliferation signals (high-dose SAC or BCPF) and four distinct BCDF preparations, so that this effect did not appear to be due to an unusual combination of B cell signals. The marked inhibition of B cell maturation was not due to a change in the kinetics of BCDF response as no PFC were detectable even when cultures were assayed up to day 12 . Furthermore, addition of BCDF to cultures up to 96 h after stimulation with BCPF did not result in any PFC response, suggesting that proliferation signals were not acting to induce receptors for BCDF . Other considerations such as depletion of nutrients in the media, cell crowding, and factors secreted from proliferating B cells were found not to play a significant role in the phenomenon described (data not shown) .
The finding that active proliferation inhibited response to BCDF led us to question whether such responses required any proliferation of B cells. Previous studies using leukemic B cells have suggested that terminal maturation can occur without proliferation (11) , but these cells may have already been beyond the proliferative stage. In our system, responses to BCDFs MOW 10 and MOPIL appeared to remain intact in the presence of concentrations of HU or thymidine known to inhibit T and B cell responses to mitogen. In contrast, similar concentrations of HU or thymidine abrogated response to two other BCDF preparations, MTP7 and RAC, as well as the more conventional differentiation signal, T cells, and PWM. Thus it appears that there are proliferation-independent as well as -dependent BCDFs, providing further evidence for the heterogeneity of BCDFs, and suggesting that some BCDFs might act at earlier stages of B cell maturation. However, since these BCDFs may be acting on already in vivoactivated B cells that had undergone proliferation, it was necessary to isolate resting Go B cells characterized by small cell volumes and the absence of surface activation markers 41`2 and Tac (26, 27) ; this was accomplished by counterflow elutriation. Addition of BCDF/MOW 10 to isolated resting cells did result in maturation to antibody-secreting cells. In fact, as might have been predicted from the earlier data, more activated B cells (with high spontaneous proliferation) did not respond to this BCDF . Rather, as has been shown by others (23), these activated Tac+ B cells differentiated in the presence of IL-2 . The combination signal of SAC (0.001 %) and IL-2 induced differentiation at virtually all stages of B cell activation, a finding that can be explained by the ability of SAC to activate B cells to become Tac+ (25) . We and others (8) (9) (10) have previously shown that resting B cells can respond to B cell proliferation signals . Recently other groups (28) (29) (30) have provided evidence that BSF1 is a differentiation factor for resting cells as well . However, in this context, differentiation was defined as the ability of this factor to induce receptors for proliferation signals or increased expression 390 TERMINAL MATURATION OF RESTING B CELLS of class II molecules and not terminal maturation, as we report here. Thus, in conjunction with the data presented in this study, and previous studies using malignant B cells or murine splenocytes (11) (12) (13) (14) , one can state that the resting B cell has a full complement of receptors for both growth and differentiation factors. The rationale for such a finding is less clear. Although the major Ig response with antigen-specific stimulation is directed against the specific antigen, there is a great deal of nonspecificity inherent in the immune response . Part of this nonspecificity may be due to the action of polyclonal BCDFs on local B cell clones, specific and nonspecific. If antigen-specific signals are weak, nonspecific signals may serve to boost the response dramatically . In the presence of antigen locally, antigen-specific B cells are more abundant and predominate in the response . The capability of resting cells to respond to these factors allows for a more rapid and dramatic response . The fine tuning of a specific immune response might come only after several antigenic challenges .
Summary
Using response to four different BCDF preparations as a model of B cell maturation, we have shown that induction of B cell proliferation abrogates terminal maturation of these cells. In fact, response to some BCDFs can occur in the presence of inhibitors of DNA replication, suggesting that there are proliferation-independent as well as proliferation-dependent BCDFs. These findings cannot be explained by changes in the kinetics of the BCDF response, nor can they be reversed by repletion of media or changing cell densities. Proliferationindependent BCDFs appear to exert their effects on dense, resting 4172-B cells rather than more activated B cells. This is in contrast to B cell differentiation signals of IL-2 alone or SAC and IL-2 in concert. These data suggest that the current models of B cell activation and maturation may require some reorganization, relegating the proliferative phase of B cell maturation to a lesser role. In addition, evidence is provided for the fact that the resting B cell may have the full complement of receptors for BCDF as well as BCGF and BCPF and may help account for the inherent nonspecificity of the immune response .
